Keith Thompson (CGT) announces the creation of Islexa

On day 1 of the World Stem Cells & Regenerative Medicine Congress, Keith Thompson, CEO of the Cell and Gene Therapy Catapult, announced, in partnership with the University of Aberdeen, the creation of a new company: Islexa. Islexa is developing an innovative method to produce laboratory grown islets, which are the organoids in charge of insulin production. This technology holds …

cell therapy, stem cells

Read the books about cell therapy logistics

  *Blog post provided by Thermo Fisher Scientific * Introduction to our Cell Therapy e-books If you have a cell-based therapy in development, then you need to consider such variables as packaging, storage, inventory management, monitoring systems, distribution, and even clinical site capabilities well before you begin to prepare the Investigational New Drug (IND) submission to the Food and Drug Administration (FDA). By sidestepping these issues …

regenerative medicine

Guest Blog: “How to deliver the magic bullet in regenerative medicine”

One concept that worked well at for World Stem Cells & Regenerative Medicine Congress 2015 was the round table sessions. To be honest, I arrived a sceptic wondering how much more I would gain from the sessions, perhaps an hour sitting uncomfortably trying to engage in debate. The answer – a window into each company’s current work or the question …

“Attracting and Sustaining Big Pharma Acquisition & Investment”

Robert Hariri of Celgene Cellular Therapeutics  joined us for Stem Cells & Regenerative Medicine Congress USA 2014 to present about ‘ Attracting and Sustaining Big Pharma Acquisition & Investment’  Download his presentation now to learn about: The value of innovation Innovation: Longer Life Through Better Medicines The payoff of biomedical innovation What attracts big pharma to our industry? …and much more! Get your copy …

“Cell Therapy Logistics: The Physics of Failure”

Dan O’Donnell of Fisher BioServices  joined us at Stem Cells & Regenerative Medicine Congress USA 2014 to present about ‘ Cell Therapy Logistics: The Physics of Failure’  Download his presentation now to understand more about: Thermal capacity Dry shipper system qualification Orientation risk The gas laws–impact …and much more! Get your copy here!  To find out more about  cell therapy logistics ,attend  Stem Cells & Regenerative Medicine …

“Streamlining the Path to Commercial Success for Cell Therapy”

Cenk Sumen of PCT Cell Therapy Services  joined us for Stem Cells & Regenerative Medicine Congress USA 2014 to present about ‘ Streamlining the Path to Commercial Success for Cell Therapy”   Download the presentation now to understand more about: Typical CAR T cell manufacturing process Technology examples for separation/volume reduction   Manufacturing constraints Unique manufacturing challenges for autologous processes …and much more! Get your …

“Bioprocess Development for Effective Scaling Up Allogenic Cell Therapy”

Biren Mistry of Celgene  joined us for Stem Cells & Regenerative Medicine Congress USA 2014 to present about ‘ Bioprocess Development for Effective Scaling Up Allogenic Cell Therapy”   Download the presentation now to understand more about: Established cell therapy platforms Emerging cell therapy platforms Benefits vs. Risks Cell Bead Separation: Key Parameters Effect of Enzyme Concentration …and much more! Get your copy here! …

“uniQure: Delivering gene therapy to patients”

Philip Astley-Sparke of uniQure  joined us at Stem Cells & Regenerative Medicine Congress USA 2014 to presnet about ‘Delivering gene therapy to patients’  Download his presentation to understand more about: Strategy of leadership in curating treatments uniQure’s Vector Platform Strategy uniQure’s leading manufacturing program …and much more! Get your copy here! If you’re interested in learning more about delivering gene therapy to patients , attend  Stem Cells …

Guest Blog: Cord blood – A real lifeline?

Another first for Terrapinn this year was the parallel Cord Blood World Europe Congress running alongside the Stem Cell and Regenerative Medicine Congress at the Business Design Centre in London, far too enticing a proposition not to pop in and take a look. Some ten years ago (or perhaps slightly more) I stood in a GMP suite staring at my …

securing funds cell therapy

How to increase your chances of securing funds for your cell therapy

Are you seeking investment to further fund your cell therapy research and development? Or perhaps you are looking for finance in order to commercialise and gain market access? Whatever the motivation, Terrapinn’s Investor Forum can help you move your business forward, closer to those patients who need your therapy the most, but act now as time is running out to …